Douglas Lane & Associates LLC Sells 548,687 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• Douglas Lane & Associates trimmed its stake in Healthpeak by 16.4%, selling 548,687 shares and leaving it with 2,801,853 shares worth about $45.05 million at quarter-end.
• Healthpeak beat Q4 expectations with $0.47 EPS (vs. $0.45 est.) and $719.4M revenue (up 3.1% YoY), and set FY2026 EPS guidance of 1.700–1.740.
• The company declared a monthly dividend of $0.1017 (payable June 26), with an ex-dividend/record date of June 15 and an indicated yield of about 7.3%.

Douglas Lane & Associates LLC trimmed its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 16.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,801,853 shares of the real estate investment trust's stock after selling 548,687 shares during the period. Douglas Lane & Associates LLC owned approximately 0.40% of Healthpeak Properties worth $45,054,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanderbilt University bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $1,263,000. Northside Capital Management LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $6,123,000. Argent Advisors Inc. bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $1,536,000. Twin City Private Wealth LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $1,148,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Healthpeak Properties by 7.0% during the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,935,397 shares of the real estate investment trust's stock worth $37,063,000 after purchasing an additional 126,322 shares in the last quarter. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $16.69 on Friday. Healthpeak Properties, Inc. has a twelve month low of $15.71 and a twelve month high of $19.68. The stock's 50 day moving average price is $17.02 and its 200-day moving average price is $17.41. The company has a market capitalization of $11.60 billion, a PE ratio of 166.87, a PEG ratio of 8.93 and a beta of 1.10. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The firm had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. During the same quarter in the previous year, the business earned $0.46 EPS. The company's revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be paid a $0.1017 dividend. The ex-dividend date is Monday, June 15th. This represents a c) annualized dividend and a yield of 7.3%. Healthpeak Properties's dividend payout ratio is presently 1,220.00%.

Analysts Set New Price Targets

DOC has been the subject of a number of recent research reports. Citigroup decreased their price objective on Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating for the company in a report on Wednesday, April 1st. Cantor Fitzgerald set a $17.00 price objective on Healthpeak Properties in a report on Monday, January 5th. The Goldman Sachs Group began coverage on Healthpeak Properties in a research note on Friday, January 9th. They issued a "neutral" rating and a $17.00 target price on the stock. Argus downgraded Healthpeak Properties from a "buy" rating to a "hold" rating in a research note on Thursday, February 5th. Finally, Wells Fargo & Company restated a "positive" rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Six research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $19.19.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.